Focus Partners Wealth
UTHR icon

Focus Partners Wealth’s United Therapeutics UTHR Stock Holding History

Focus Partners Wealth’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.29M Buy
6,078
+224
+4% +$126K ﹤0.01% 1135
2026
Q1 		$3.47M Sell
5,854
-785
-12% -$391K ﹤0.01% 1076
2025
Q4 		$3.23M Buy
6,639
+3,859
+139% +$1.8M ﹤0.01% 1129
2025
Q3 		$1.17M Buy
2,780
+416
+18% +$140K ﹤0.01% 1222
2025
Q2 		$679K Buy
2,364
+906
+62% +$271K ﹤0.01% 1294
2025
Q1 		$449K Sell
1,458
-466
-24% -$160K ﹤0.01% 1389
2024
Q4 		$679K Buy
1,924
+1,080
+128% +$397K ﹤0.01% 1201
2024
Q3 		$302K Buy
+844
New +$285K ﹤0.01% 1324

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Focus Partners Wealth's UTHR Position: Q2 2026 in Review

Focus Partners Wealth increased its United Therapeutics (UTHR) stake by 3.8% in Q2 2026, buying an estimated $126K and bringing the position to 6,078 shares worth $3.29M. The position accounts for ﹤0.01% of the portfolio, ranked #1135.

Focus Partners Wealth first reported a position in UTHR in Q3 2024 and has held it in 8 quarters since. The position peaked at $3.47M in Q1 2026. 880 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Focus Partners Wealth held 6,078 shares of United Therapeutics worth $3.29M as of Q2 2026.
  • Focus Partners Wealth bought 224 United Therapeutics shares in Q2 2026, an estimated $126K.
  • United Therapeutics made up ﹤0.01% of Focus Partners Wealth's portfolio in Q2 2026, its #1135 holding.
  • Focus Partners Wealth first reported a position in United Therapeutics in Q3 2024 and has held it in 8 quarters since.
  • Focus Partners Wealth's United Therapeutics position peaked at $3.47M in Q1 2026.
  • 880 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Focus Partners Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.